All manner of clinical practice guidelines for prevention of cancers, surveillance and early detection, and any other clinical management for persons at high risk of, but not diagnosed with cancer. Also includes any practice guidelines for the prevention or detection of new cancers in cancer patients and survivors.
Not just clinical guidelines themselves, but any papers dealing with any aspect of guidelines, such as assessments of their effectiveness, assessments of providers' adherence to guidelines, press reports announcing new guideline's release, and so forth.
List was last updated on
.-
- Study: Women who exercise have lower breast cancer risk whether or not they have a family history of breast cancer.
- [No author given.]
- FORCE. XRAYS. 2019 Dec 6.
- Research news
- Free Full Text
Original research:
Recreational physical activity is associated with reduced breast cancer risk in adult women at high risk for breast cancer: a cohort study of women selected for familial and genetic risk.
- PMID: 31578201
- PubMed abstract
- Source abstract
-
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, NCCN Guidelines Version 1.2020.
- Daly MB, Pilarski R, Berry M, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian A, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB.
- 2020 Dec 4.
NCCN Guidelines menu: NCCN Guidelines For Detection, Prevention, & Risk Reduction (National Comprehensive Cancer Network)
NCCN Guidelines (PDF): Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic - Version 1.2020 — December 4, 2020 (National Comprehensive Cancer Network)
Press: NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk. (GenomeWeb)
-
- Update: Genetic causes of hereditary pancreatic cancer: BRCA and beyond
- [No author given]
- FORCE. XRAYS. 2019 Nov 26.
- Review
- Free Full Text
-
- Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication.
- Evans DG, Edwards M, Duffy SW; Cancer Genetics Group clinical leads, Tischkowitz M.
- Br J Cancer. 2019 Nov 25. doi: 10.1038/s41416-019-0631-2. [Epub ahead of print]
- PMID: 31761901
- PubMed abstract
- Source abstract
-
- Men With BRCA2 Should Be Screened for Prostate Cancer.
- Davenport L.
- Medscape Oncology. 2019 Nov 8.
- Research news, Conference report
- Free Full Text
Original research:
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
- PMID: 31537406
- PubMed abstract
- Free Full Text
-
- [What attitude to women at high risk of breast cancer?]
- Livon D, Moretta J, Noguès C.
- Presse Med. 2019 Nov 6. pii: S0755-4982(19)30302-1. doi: 10.1016/j.lpm.2019.07.014. [Epub ahead of print]
- PMID: 31706893
- PubMed abstract
- Source abstract
-
- Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
- Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K, Johansen Taber K.
- Cancer. 2019 Nov 4. doi: 10.1002/cncr.32572. [Epub ahead of print]
- PMID: 31682005
- PubMed abstract
-
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
- Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, Bassi C, Carrato A, Farrell J, Fishman E, Fockens P, Gress TM, van Hooft JE, Hruban RH, Kastrinos F, Klein A, Lennon AM, Lucas A, Park W, Rustgi A, Simeone D, Stoffel E, Vasen HFA, Cahen DL, Canto MI, Bruno M; International Cancer of the Pancreas Screening (CAPS) consortium.
- Gut. 2019 Oct 31. pii: gutjnl-2019-319352. doi: 10.1136/gutjnl-2019-319352. [Epub ahead of print]
- PMID: 31672839
- PubMed abstract
- Source abstract
Press: At-Risk Individuals Need Surveillance for Familial Pancreatic Cancer. (Medscape/Reuters)
-
- Prostate cancer genetic testing: NCCN familial high-risk assessment: breast/ovarian.
- Daly MB.
- Can J Urol. 2019 Oct;26(5S2):29-30.
- PMID: 31629424
- PubMed abstract
- Source abstract
- Review
- Free Full Text (PDF)
-
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
- Page EC, Bancroft EK, Brook MN, Assel M, Hassan Al Battat M, Thomas S, Taylor N, Chamberlain A, Pope J, Raghallaigh HN, Evans DG, Rothwell J, Mahle L, Grindedal EMM, James P, Mascarenhas L, McKinley J, Side L, Thomas T, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Jensen TD, Osther PJS, Helfand BT, Genova E, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Lam J, Taylor L, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams W, Cook J, Rosario DJ, Domchek S, Powers J, Buys S, O'Toole K, Ausems MGEM, Schmutzler RK, Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, van Randeraad H, Davidson R, Longmuir M, Ruijs MWG, Helderman van den Enden ATJM, Adank M, Williams R, Andrews L, Murphy DG, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Morton C, Shackleton K, Snape K, Hanson H, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Ramon Y Cajal T, Zgajnar J, Brewer C, Gadea N, Brady AF, van Os T, Gallagher D, Johannsson O, Donaldson A, Barwell J, Nicolai N, Friedman E, Obeid E, Greenhalgh L, Murthy V, Copakova L, Saya S, McGrath J, Cooke P, Rønlund K, Richardson K, Henderson A, Teo SH, Arun B, Kast K, Dias A, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Eyfjord J, Falconer A, Foster C, Gronberg H, Hamdy FC, Stefansdottir V, Khoo V, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Moynihan C, Rennert G, Suri M, Wilson P, Dudderidge T; IMPACT Study Collaborators, Offman J, Kote-Jarai Z, Vickers A, Lilja H, Eeles RA.
- Eur Urol. 2019 Sep 12. pii: S0302-2838(19)30668-2. doi: 10.1016/j.eururo.2019.08.019. [Epub ahead of print]
- PMID: 31537406
- PubMed abstract
Research news, Conference report: Men With BRCA2 Should Be Screened for Prostate Cancer. (Medscape)
Research news: The IMPACT of BRCA2 in prostate cancer. (Nature Reviews Urology)
-
- Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
- US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Tseng CW, Wong JB.
- JAMA. 2019 Sep 3;322(9):857-867. doi: 10.1001/jama.2019.11885.
- PMID: 31479144
- PubMed abstract
- Guidelines
- Free Full Text
Guidelines:
Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- PMID: 31479143
- PubMed abstract
- Free Full Text
Editorial:
Medications to Reduce Breast Cancer Risk: Promise and Limitations.
- PMID: 31479121
- PubMed abstract
- Free Full Text
Patient Page:
Medications to Reduce Breast Cancer Risk.
- PMID: 31479139
- PubMed abstract
- Free Full Text
Audio Interview/CME: USPSTF Recommendation: Medication Use to Reduce Risk of Breast Cancer. (JN Learning)
-
- Breast Cancer Screening in BRCA Mutation Carriers: Necessity of a Relevant Update of Mammographic Modalities.
- Colin C, Doutriaux-Dumoulin I.
- Radiology. 2019 Sep 3:191306. doi: 10.1148/radiol.2019191306. [Epub ahead of print]
- PMID: 31478804
- PubMed abstract
- Source abstract
Original research:
BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
- PMID: 31038410
- PubMed abstract
- Free Full Text
-
- Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
- Wilhite AM, Oestreich MC, Olson M, Bedell SM, Westenberg D, Bangdiwala A, Ikramuddin S, Sanchez-Avila M, Madoff RD, Khalifa MA, Erickson BK.
- Obstet Gynecol. 2019 Sep;134(3):520-526. doi: 10.1097/AOG.0000000000003421.
- PMID: 31403600
- PubMed abstract
- Source abstract
-
- Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants.
- Walker M, Jacobson M, Sobel M.
- CMAJ. 2019 Aug 12;191(32):E886-E893. doi: 10.1503/cmaj.190281.
- PMID: 31405835
- PubMed abstract
- Review
- Free Full Text
-
- Screening for Pancreatic Cancer.
- Lucas AL, Kastrinos F.
- JAMA. 2019 Aug 6;322(5):407-408. doi: 10.1001/jama.2019.9690.
- PMID: 31386115
- PubMed abstract
- Editorial
- Free Full Text
Guidelines:
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement.
- PMID: 31386141
- PubMed abstract
- Free Full Text
Editorial:
Screening for Pancreatic Cancer Gets a D, But the Student Is Improving.
- PMID: 31386099
- PubMed abstract
- Source abstract
Editorial:
Screening for Pancreatic Cancer-Is There Hope?
- PMID: 31386154
- PubMed abstract
- Source abstract
-
- Combined hormonal contraceptives in BRCA gene mutation carriers: why not?
- Grandi G, Sammarini M, Chiara Del Savio M, Toss A, Facchinetti F.
- Eur J Contracept Reprod Health Care. 2019 Jul 30:1-3. doi: 10.1080/13625187.2019.1647335. [Epub ahead of print]
- PMID: 31361161
- PubMed abstract
-
- [Hereditary Breast and Ovarian Cancer Syndrome].
- Inuzuka M, Nakamura S.
- Gan To Kagaku Ryoho. 2019 Jul;46(7):1109-1113.
- PMID: 31296812
- PubMed abstract
-
- Multi gene panel testing for hereditary breast cancer - is it ready to be used?
- Catana A, Apostu AP, Antemie RG.
- Med Pharm Rep. 2019 Jul;92(3):220-225. doi: 10.15386/mpr-1083. Epub 2019 Jul 31.
- PMID: 31460501
- PubMed abstract
- Source abstract
-
- Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families.
- Lakeman IMM, Hilbers FS, Rodríguez-Girondo M, Lee A, Vreeswijk MPG, Hollestelle A, Seynaeve C, Meijers-Heijboer H, Oosterwijk JC, Hoogerbrugge N, Olah E, Vasen HFA, van Asperen CJ, Devilee P.
- J Med Genet. 2019 Jun 11. pii: jmedgenet-2019-106072. doi: 10.1136/jmedgenet-2019-106072. [Epub ahead of print]
- PMID: 31186341
- PubMed abstract
- Source abstract
-
- A young woman's story of genetic testing and risk-reducing mastectomy.
- [No author given]
- FORCE. XRAYS. 2019 Jun 6.
- Commentary
- Free Full Text
Narrative: I Had a Preventive Mastectomy—Then Found Out I Already Had Breast Cancer. (Health)
-
- [Risks of Solid Tumors in Heterozygous Carriers of Recessive Syndromes.]
- Koudová M, Puchmajerová A.
- Klin Onkol. 2019 Summer;32(Supplementum2):14-23. doi: 10.14735/amko2019S14.
- PMID: 31409077
- PubMed abstract
- Source abstract
- Review, [Article in Czech], English Abstract
- Free Full Text - Czech (PDF)
-
- "Decoding hereditary breast cancer" benefits and questions from multigene panel testing.
- Colas C, Golmard L, de Pauw A, Caputo SM, Stoppa-Lyonnet D.
- Breast. 2019 Jun;45:29-35. doi: 10.1016/j.breast.2019.01.002. Epub 2019 Jan 8.
- PMID: 30822622
- PubMed abstract
- Source abstract
-
- Concurrent hysterectomy at the tine of risk-reducing surgery for patients with BRCA mutations.
- Gordhandas S, Ruiz MP, Talukdar N, Holcomb KM, Freya MK, Chapman-Davis E, Kahn RM.
- Gynecol Oncol. 2019 Jun;153(3):e12-e13. doi: 10.1016/j.ygyno.2019.03.134.
-
- Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?
- Catanzarite T, Eskander RN.
- Female Pelvic Med Reconstr Surg. 2019 May 22. doi: 10.1097/SPV.0000000000000741. [Epub ahead of print]
- PMID: 31135579
- PubMed abstract
- Source abstract
-
- Germline and Somatic Mutations in Prostate Cancer for the Clinician.
- Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.
- J Natl Compr Canc Netw. 2019 May 1;17(5):515-521. doi: 10.6004/jnccn.2019.7307.
- PMID: 31085765
- PubMed abstract
- Review
- Free Full Text
-
- BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
- Elezaby M, Lees B, Maturen KE, Barroilhet L, Wisinski KB, Schrager S, Wilke LG, Sadowski E.
- Radiology. 2019 Apr 30:181814. doi: 10.1148/radiol.2019181814. [Epub ahead of print]
- PMID: 31038410
- PubMed abstract
- Source abstract
- Review
- Free Full Text
Letter, Comment:
Breast Cancer Screening in BRCA Mutation Carriers: Necessity of a Relevant Update of Mammographic Modalities.
- PMID: 31478804
- PubMed abstract
- Source abstract
-
- Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs).
- Talukdar S, Hawkes L, Hanson H, Kulkarni A, Brady AF, McMullan DJ, Ahn JW, Woodward E, Turnbull C; UK Association for Clinical Genomic Science and UK Cancer Genetics Group.
- J Med Genet. 2019 Apr 24. pii: jmedgenet-2018-105820. doi: 10.1136/jmedgenet-2018-105820. [Epub ahead of print]
- PMID: 31018999
- PubMed abstract
- Source abstract
-
- What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.
- Franceschini G, Masetti R.
- Eur J Breast Health. 2019 Apr 1;15(2):135-136. doi: 10.5152/ejbh.2019.4651. eCollection 2019 Apr.
- PMID: 31001617
- PubMed abstract
- Source abstract
- Letter, Review
- Free PMC article
- Free Full Text (PDF)
Review:
Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
- PMID: 30288491
- PubMed abstract
- Source abstract
-
- Genetic counselling of young women with breast cancer for Li-Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals.
- Bakhuizen JJ, Velthuizen ME, Stehouwer S, Bleiker EM, Ausems MG.
- Fam Cancer. 2019 Apr;18(2):231-239. doi: 10.1007/s10689-018-0103-5.
- PMID: 30238178
- PubMed abstract
-
- Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines.
- Vermeulen RFM, Korse CM, Kenter GG, Brood-van Zanten MMA, Beurden MV.
- Climacteric. 2019 Mar 25:1-9. doi: 10.1080/13697137.2019.1582622. [Epub ahead of print]
- PMID: 30905183
- PubMed abstract
- Source abstract
-
- Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.
- Suarez-Kelly LP, Yu L, Kline D, Schneider EB, Agnese DM, Carson WE.
- Hered Cancer Clin Pract. 2019 Mar 25;17:12. doi: 10.1186/s13053-019-0110-z. eCollection 2019.
- PMID: 30962859
- PubMed abstract
-
- A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer.
- Forbes C, Fayter D, de Kock S, Quek RG.
- Cancer Manag Res. 2019 Mar 22;11:2321-2337. doi: 10.2147/CMAR.S189627. eCollection 2019.
- PMID: 30962720
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Trends in Breast MRI Use Among Women with BRCA Mutations: A National Claims Analysis 2006–2016.
- Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK.
- Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):624. doi: 10.1158/1055-9965.EPI-19-0079.
-
- Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom.
- Autier P.
- JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6501. [Epub ahead of print]
- PMID: 30653221
- PubMed abstract
- Source abstract
Letter, Reply:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.
- PMID: 30653219
- PubMed abstract
- Source abstract
Original research:
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
- PMID: 29978189
- PubMed abstract
- Free Full Text
-
- 'Taking Back Control': The Growth in Prophylactic Mastectomy.
- Davenport L.
- Medscape. Medscape Oncology. 2019 Jan 10.
- News
- Free Full Text
Press: 'We've Scared Women': The Growth of Prophylactic Mastectomy (Medscape Oncology)
-
- Draft Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk.
- U.S. Preventive Services Task Force
- U.S. Preventive Services Task Force. January 2019.
- Recommendation Statement
- Free Full Text
Press: USPSTF Reaffirms Drugs for Women at High Risk for Breast Cancer. (Medscape Oncology)
-
- Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
- Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.
- Ann Ital Chir. 2019;90:1-2.
- PMID: 30872561
- PubMed abstract
-
- [Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
- Amat L, Bulach A, Leclercq M, Mesrine S, Scheffler F, Sperandeo D, Scheffler M.
- Gynecol Obstet Fertil Senol. 2018 Dec;46(12):883-888. doi: 10.1016/j.gofs.2018.10.013. Epub 2018 Nov 7.
- PMID: 30414725
- PubMed abstract
- Source abstract
-
- Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.
- Santana Dos Santos E, Lallemand F, Burke L, Stoppa-Lyonnet D, Brown M, Caputo SM, Rouleau E.
- Cancers (Basel). 2018 Nov 16;10(11). pii: E453. doi: 10.3390/cancers10110453.
- PMID: 30453575
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
- Pashayan N, Morris S, Gilbert FJ, Pharoah PDP.
- JAMA Oncol. 2018 Nov 1;4(11):1504-1510. doi: 10.1001/jamaoncol.2018.1901.
- PMID: 29978189
- PubMed abstract
Editorial:
Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine.
- PMID: 29978191
- PubMed abstract
- Source abstract
Audio Interview: Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening. (JAMA Oncology)
Press: Breast Cancer Screening Only for Women at Higher Risk. (Medscape)
Letter, Comment:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom
Letter, Reply:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom—Reply.
-
- Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
- Piszczek C, Ma J, Gould CH, Tseng P.
- J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1179-1193. doi: 10.1016/j.jmig.2017.10.025. Epub 2017 Oct 31.
- PMID: 29097232
- PubMed abstract
- Source abstract
-
- Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
- Theobald KA, Susswein LR, Marshall ML, Roberts ME, Mester JL, Speyer D, Williams RNW, Knapke SC, Solomon SR, Murphy PD, Klein RT, Hruska KS, Solomon BD.
- Ann Surg Oncol. 2018 Nov;25(12):3556-3562. doi: 10.1245/s10434-018-6581-8. Epub 2018 Aug 30.
- PMID: 30167906
- PubMed abstract
- Source abstract
-
- Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
- Lee K, Krempely K, Roberts ME, Anderson MJ, Carneiro F, Chao E, Dixon K, Figueiredo J, Ghosh R, Huntsman D, Kaurah P, Kesserwan C, Landrith T, Li S, Mensenkamp AR, Oliveira C, Pardo C, Pesaran T, Richardson M, Slavin TP, Spurdle AB, Trapp M, Witkowski L, Yi CS, Zhang L, Plon SE, Schrader KA, Karam R.
- Hum Mutat. 2018 Nov;39(11):1553-1568. doi: 10.1002/humu.23650.
- PMID: 30311375
- PubMed abstract
- Source abstract
-
- No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
- Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L.
- J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046.
- PMID: 30473125
- PubMed abstract
- Source abstract
[Article in French]:
No 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.
- PMID: 30473126
- PubMed abstract
- Source abstract
-
- Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
- Nielsen SM, Eccles DM, Romero IL, Al-Mulla F, Balmaña J, Biancolella M, Bslok R, Caligo MA, Calvello M, Capone GL, Cavalli P, Chan TLC, Claes KBM, Cortesi L, Couch FJ, de la Hoya M, De Toffol S, Diez O, Domchek SM, Eeles R, Efremidis A, Fostira F, Goldgar D, Hadjisavvas A, Hansen TVO, Hirasawa A, Houdayer C, Kleiblova P, Krieger S, Lázaro C, Loizidou M, Manoukian S, Mensenkamp AR, Moghadasi S, Monteiro AN, Mori L, Morrow A, Naldi N, Nielsen HR, Olopade OI, Pachter NS, Palmero EI, Pedersen IS, Piane M, Puzzo M, Robson M, Rossing M, Sini MC, Solano A, Soukupova J, Tedaldi G, Teixeira M, Thomassen M, Tibiletti MG, Toland A, Törngren T, Vaccari E, Varesco L, Vega A, Wallis Y, Wappenschmidt B, Weitzel J, Spurdle AB, De Nicolo A, Gómez-García EB.
- JCO Precis Oncol. 2018;2. doi: 10.1200/PO.18.00091. Epub 2018 Oct 26.
- PMID: 31517176
- PubMed abstract
-
- Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
- Jatoi I.
- Eur J Breast Health. 2018 Oct 1;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct.
- PMID: 30288491
- PubMed abstract
- Source abstract
Letter, Review:
What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.
- PMID: 31001617
- PubMed abstract
- Source abstract
-
- New Breast Cancer Screening Guidelines Build on Progress.
- Larsen Haidle J.
- NSGC blog, 2018 Oct 1.
- Blog post
- Free Full Text
Guidelines: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian (PDF) (NCCN.org)
-
- [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
- Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, Corsini C, Cusin V, De Pauw A, Delnatte C, Dussart S, Jamain C, Longy M, Luporsi E, Maugard C, Nguyen TD, Pujol P, Vaur D, Andrieu N, Lasset C, Noguès C; Groupe Génétique et Cancer d’Unicancer.
- Bull Cancer. 2018 Oct;105(10):907-917. doi: 10.1016/j.bulcan.2018.08.003. Epub 2018 Sep 27.
- PMID: 30268633
- PubMed abstract
- Source abstract
-
- The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
- Braude L, Kirsten L, Gilchrist J, Juraskova I.
- Psychooncology. 2018 Oct;27(10):2349-2356. doi: 10.1002/pon.4830. Epub 2018 Sep 4.
- PMID: 29966172
- PubMed abstract
- Source abstract
-
- Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
- Yoshimura A, Okumura S, Sawaki M, Hattori M, Ishiguro J, Adachi Y, Kotani H, Gondo N, Kataoka A, Iwase M, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Takaiso N, Hyodo I, Iwata H.
- Breast Cancer. 2018 Sep;25(5):539-546. doi: 10.1007/s12282-018-0850-z. Epub 2018 Mar 8.
- PMID: 29520501
- PubMed abstract
- Source abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Breast Cancer Genetics and Indications for Prophylactic Mastectomy.
- Krontiras H, Farmer M, Whatley J.
- Surg Clin North Am. 2018 Aug;98(4):677-685. doi: 10.1016/j.suc.2018.03.004. Epub 2018 May 30.
- PMID: 30005767
- PubMed abstract
- Source abstract
-
- The National Comprehensive Cancer Network (NCCN) Guidelines Have Been Updated: Here is What You Need to Know.
- [No author given]
- My Gene Counsel. 2018 Jul 23.
- Blog post
- Free Full Text
Guidelines: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian (PDF) (NCCN.org)
-
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian
- Daly MB, Pilarski R, Berry M, Buys SS, Friedman S, Garber JE, Hutton ML, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Laronga C, Litton JK, Madlensky L, Mac JS, Merajver SD, Offit K, Pal T, Peterson HJ, Reiser G, Shannon KM, Thaker P, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Darlow S.
- NCCN.org. 2018 Jul 11. Version 1.2019.
- Guidelines
- Free Full Text (PDF - Registration required)
-
- 'We've Scared Women': The Growth of Prophylactic Mastectomy.
- Davenport L.
- Medscape. Medscape Oncology. 2018 Jul 3.
- Review, Commentary
- Free Full Text
Press: 'Taking Back Control': The Growth in Prophylactic Mastectomy (Medscape Oncology)
-
- Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.
- Kearton S, Wills K, Bunting M, Blomfield P, James PA, Burke J.
- Fam Cancer. 2018 Jul;17(3):333-344. doi: 10.1007/s10689-017-0047-1.
- PMID: 29039136
- PubMed abstract
- Source abstract
-
- Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
- Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.
- J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21.
- PMID: 29929997
- PubMed abstract
- Source abstract
-
- Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer.
- Franc BL, Copeland TP, Thombley R, Park M, Marafino B, Dean ML, Boscardin WJ, Rugo HS, Seidenwurm D, Sharma B, Johnston SR, Dudley RA.
- J Natl Compr Canc Netw. 2018 Jul;16(7):829-837. doi: 10.6004/jnccn.2018.7024.
- PMID: 30006425
- PubMed abstract
- Source abstract
-
- Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.
- Mano R, Tamir S, Kedar I, Benjaminov O, Baniel J, Tabachnik T, Margel D.
- JAMA Oncol. 2018 Jun 1;4(6):872-874. doi: 10.1001/jamaoncol.2018.0271.
- PMID: 29710070
- PubMed abstract
- Source abstract
-
- Nipple-sparing mastectomy in women at high risk of developing breast cancer.
- Lewis RS, George A, Rusby JE.
- Gland Surg. 2018 Jun;7(3):325-336. doi: 10.21037/gs.2018.04.01.
- PMID: 29998082
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Recommendations on prevention and screening for breast cancer in Hong Kong.
- Lam TH, Wong KH, Chan KK, Chan MC, Chao DV, Cheung AN, Fan CY, Ho J, Hui EP, Lam KO, Law CK, Law WL, Loong HH, Ngan RK, Tsang TH, Wong MC, Yeung RM, Ying AC, Ching R.
- Hong Kong Med J. 2018 Jun;24(3):298-306. doi: 10.12809/hkmj177037.
- PMID: 29926793
- PubMed abstract
-
- Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
- Frost AS, Toaff M, Biagi T, Stark E, McHenry A, Kaltman R.
- Obstet Gynecol. 2018 Jun;131(6):1103-1110. doi: 10.1097/AOG.0000000000002531.
- PMID: 29742654
- PubMed abstract
- Source abstract
-
- Ovarian Cancer Prevention and Screening.
- Menon U, Karpinskyj C, Gentry-Maharaj A.
- Obstet Gynecol. 2018 May;131(5):909-927. doi: 10.1097/AOG.0000000000002580.
- PMID: 29630008
- PubMed abstract
- Source abstract
-
- [Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
- Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.
- Rev Esp Patol. 2018 Apr - Jun;51(2):84-96. doi: 10.1016/j.patol.2017.11.002. Epub 2018 Jan 17.
- PMID: 29602379
- PubMed abstract
- Source abstract
-
- Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.
- Gast KC, Viscuse PV, Nowsheen S, Haddad TC, Mutter RW, Wahner Hendrickson AE, Couch FJ, Ruddy KJ.
- Curr Treat Options Cardiovasc Med. 2018 Mar 1;20(2):18. doi: 10.1007/s11936-018-0609-z.
- PMID: 29497862
- PubMed abstract
- Source abstract
-
- Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.
- US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW.
- JAMA. 2018 Feb 13;319(6):588-594. doi: 10.1001/jama.2017.21926.
- PMID: 29450531
- PubMed abstract
- Source abstract
- Recommendation Statement
- Free Full Text
Evidence Report, Review:
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
- PMID: 29450530
- PubMed abstract
- Source abstract
Editorial: Screening for Ovarian Cancer in Asymptomatic Women (JAMA)
Editorial: The Yet Unrealized Promise of Ovarian Cancer Screening (JAMA Oncology)
Editorial: Is There a Future for Ovarian Cancer Screening? (JAMA Internal Medicine)
JAMA Patient Page: Screening for Ovarian Cancer (JAMA)
Press: 'No' to Ovarian Cancer Screening: Harms Outweigh Benefits. (Medscape)
-
- Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- Henderson JT, Webber EM, Sawaya GF.
- JAMA. 2018 Feb 13;319(6):595-606. doi: 10.1001/jama.2017.21421.
- PMID: 29450530
- PubMed abstract
- Source abstract
- Evidence Report
- Free Full Text
Recommendation Statement:
Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 29450531
- PubMed abstract
- Source abstract
Editorial: Screening for Ovarian Cancer in Asymptomatic Women (JAMA)
Editorial: The Yet Unrealized Promise of Ovarian Cancer Screening (JAMA Oncology)
Editorial: Is There a Future for Ovarian Cancer Screening? (JAMA Internal Medicine)
JAMA Patient Page: Screening for Ovarian Cancer (JAMA)
Press: 'No' to Ovarian Cancer Screening: Harms Outweigh Benefits. (Medscape)
-
- Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
- Wright FC, Look Hong NJ, Quan ML, Beyfuss K, Temple S, Covelli A, Baxter N, Gagliardi AR.
- Ann Surg. 2018 Feb;267(2):271-279. doi: 10.1097/SLA.0000000000002309.
- PMID: 28594745
- PubMed abstract
- Source abstract
-
- "I've just never gotten around to doing it": Men's approaches to managing BRCA-related cancer risks.
- Rauscher EA, Dean M.
- Patient Educ Couns. 2018 Feb;101(2):340-345. doi: 10.1016/j.pec.2017.07.015. Epub 2017 Jul 23.
- PMID: 28757302
- PubMed abstract
- Source abstract
-
- Hereditary diffuse gastric cancer: One family's story.
- Zylberberg HM, Sultan K, Rubin S.
- World J Clin Cases. 2018 Jan 16;6(1):1-5. doi: 10.12998/wjcc.v6.i1.1.
- PMID: 29376063
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
-
- Quality-of-life implications of risk-reducing cancer surgery.
- Altman AM, Hui JYC, Tuttle TM.
- Br J Surg. 2018 Jan;105(2):e121-e130. doi: 10.1002/bjs.10725.
- PMID: 29341149
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Development of a high risk pancreatic screening clinic using 3.0 T MRI.
- Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S.
- Fam Cancer. 2018 Jan;17(1):101-111. doi: 10.1007/s10689-017-0057-z.
- PMID: 29101607
- PubMed abstract
- Source abstract
Editorial, Research Introduction: The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer. (Familial Cancer)
-
- [Exclusive salpingectomy or prophylactic salpingo-oophorectomy? Critical analysis of the latest French guidelines].
- Chene G, Lamblin G.
- Gynecol Obstet Fertil Senol. 2018 Jan;46(1):1-3. doi: 10.1016/j.gofs.2017.10.013. Epub 2017 Dec 6.
- PMID: 29203396
- PubMed abstract
- Editorial, [Article in French]
- Free Full Text
-
- Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer.
- Manchanda R, Menon U.
- Int J Gynecol Cancer. 2018 Jan;28(1):34-42. doi: 10.1097/IGC.0000000000001147.
- PMID: 30814216 , 29252925
- PubMed abstract
- Source abstract
-
- Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
- Powers B, Pal T, Laronga C.
- Surg Oncol Clin N Am. 2018 Jan;27(1):1-22. doi: 10.1016/j.soc.2017.08.003.
- PMID: 29132555
- PubMed abstract
- Source abstract
-
- [Current German and American guidelines for autologous fat grafting - a transatlantic comparison].
- Broelsch GF, Könneker S, Ipaktchi R, Vogt PM.
- Handchir Mikrochir Plast Chir. 2017 Dec;49(6):408-414. doi: 10.1055/s-0043-118595. Epub 2017 Dec 29.
- PMID: 29287289
- PubMed abstract
- Source abstract
-
- Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. Clinical Management of Carriers of BRCA Pathogenic Variants. Available Clinical Practice Guidelines for Hereditary Breast and Ovarian Cancer.
- PDQ Cancer Genetics Editorial Board.
- PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute. Updated 2017 Nov 30. Accessed 2017 Dec 8.
- PMID: 26389210
- PubMed abstract
- Section link
-
- Clinical implications of germline mutations in breast cancer: TP53.
- Schon K, Tischkowitz M.
- Breast Cancer Res Treat. 2017 Oct 16. doi: 10.1007/s10549-017-4531-y. [Epub ahead of print]
- PMID: 29039119
- PubMed abstract
- Review
- Free Full Text
-
- Impact of germline and somatic BRCA1/2 mutations: Tumor spectrum and detection platforms.
- Wu H, Wu X, Liang Z.
- Gene Ther. 2017 Oct;24(10):601-609. doi: 10.1038/gt.2017.73. Epub 2017 Aug 3.
- PMID: 28771233
- PubMed abstract
- Source abstract
-
- ACOG's Updated Breast and Ovarian Cancer Syndrome Guidance: What to Know.
- Kaunitz AM.
- Medscape. News & Perspective. 2017 Sep 26.
- News, Commentary
- Free Full Text
-
- Final report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology, on a fact-finding questionnaire on the status of treatment of hereditary breast and ovarian cancer syndrome in Japan.
- Satoh T, Takamatsu K, Takeshima N, Kobayashi H, Aoki D, Suzuki N.
- J Obstet Gynaecol Res. 2017 Sep;43(9):1377-1380. doi: 10.1111/jog.13409. Epub 2017 Aug 17.
- PMID: 28833906
- PubMed abstract
- Source abstract
- Committee report, Guidelines
- Free Full Text
-
- Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
- Committee on Gynecologic Practice, Society of Gynecologic Oncology.
- Obstet Gynecol. 2017 Sep;130(3):e146-e149. doi: 10.1097/AOG.0000000000002299.
- PMID: 28832487
- PubMed abstract
- Committee Opinion, Guidelines
- Free Full Text
Summary:
Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
- PMID: 28832478
- PubMed abstract
- Free Full Text
-
- ['Healthy sick' or: How Genetic Risks Lever the Disease Concept of the Healthcare System].
- Meier F, Ried J, Braun M, Dabrock P.
- Gesundheitswesen. 2017 Aug;79(8-09):594-598. doi: 10.1055/s-0043-109862. Epub 2017 Jul 14.
- PMID: 28709175
- PubMed abstract
- Source abstract
-
- Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
- [No authors listed]
- Obstet Gynecol. 2017 Jul;130(1):e1-e16. doi: 10.1097/AOG.0000000000002158.
- PMID: 28644335
- PubMed abstract
- Source abstract
- Practice Guideline
- Free Full Text
Summary:
Practice Bulletin No. 179 Summary: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
- PMID: 28644328
- PubMed abstract
- Free Full Text
-
- No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
- Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
- J Obstet Gynaecol Can. 2017 Jun;39(6):480-493. doi: 10.1016/j.jogc.2016.12.005.
- PMID: 28527613
- PubMed abstract
- Source abstract
Practice Guideline, Review, [Article in French]:
No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale.
- PMID: 28527614
- PubMed abstract
- Source abstract
-
- No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale.
- Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
- J Obstet Gynaecol Can. 2017 Jun;39(6):494-508. doi: 10.1016/j.jogc.2017.03.121.
- PMID: 28527614
- PubMed abstract
- Source abstract
Practice Guideline, Review, English Abstract:
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
- PMID: 28527613
- PubMed abstract
- Source abstract
-
- Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
- Pérez-López FR, Ceausu I, Depypere H, Kehoe S, Lambrinoudaki I, Mueck A, Senturk LM, Simoncini T, Stevenson JC, Stute P, Rees M.
- Maturitas. 2017 Jun;100:86-91. doi: 10.1016/j.maturitas.2017.03.003. Epub 2017 Mar 15.
- PMID: 28389043
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
- Afghahi A, Kurian AW.
- Curr Treat Options Oncol. 2017 May;18(5):27. doi: 10.1007/s11864-017-0468-y.
- PMID: 28439798
- PubMed abstract
- Free Full Text
-
- Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
- Hermel DJ, McKinnon WC, Wood ME, Greenblatt MS.
- Fam Cancer. 2017 Jan;16(1):159-166. doi: 10.1007/s10689-016-9913-5.
- PMID: 27401692
- PubMed abstract
- Source abstract
Letter:
Patients with negative multi-gene panel testing: a back to the future paradox?
- PMID: 28258424
- PubMed abstract
- Free Full Text
Letter:
Placing negative multi-gene panel results into clinical context.
- PMID: 28455554
- PubMed abstract
- Free Full Text
-
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
- Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S.
- J Natl Compr Canc Netw. 2017 Jan;15(1):9-20.
- PMID: 28040716
- PubMed abstract
- Source abstract
- Guidelines
- Free Full Text
Comments from NSGC Discussion Forum Cancer SIG
Subject: Always Handy
NCCN Guidelines menu: Recent Updates to NCCN Clinical Practice Guidelines in Oncology (National Comprehensive Cancer Network)
NCCN Guidelines (PDF): Genetic/Familial High-Risk Assessment: Breast and Ovarian - Version 2.2017 — December 7, 2016 (National Comprehensive Cancer Network)
-
- Breast Cancer Epidemiology, Prevention, and Screening.
- Winters S, Martin C, Murphy D, Shokar NK.
- Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10.
- PMID: 29096890
- PubMed abstract
- Source abstract
-
- Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
- Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE.
- Breast Cancer Res Treat. 2016 Dec;160(3):393-410. Epub 2016 Oct 12.
- PMID: 27734215
- PubMed abstract
- Source abstract
-
- Recommendations for breast imaging follow-up of women with a previous history of breast cancer: position paper from the Italian Group for Mammography Screening (GISMa) and the Italian College of Breast Radiologists (ICBR) by SIRM.
- Bucchi L, Belli P, Benelli E, Bernardi D, Brancato B, Calabrese M, Carbonaro LA, Caumo F, Cavallo-Marincola B, Clauser P, Fedato C, Frigerio A, Galli V, Giordano L, Golinelli P, Mariscotti G, Martincich L, Montemezzi S, Morrone D, Naldoni C, Paduos A, Panizza P, Pediconi F, Querci F, Rizzo A, Saguatti G, Tagliafico A, Trimboli RM, Zuiani C, Sardanelli F.
- Radiol Med. 2016 Dec;121(12):891-896. Epub 2016 Sep 6.
- PMID: 27601142
- PubMed abstract
- Practice Guideline
- Free Full Text
-
- Providing Balance in ASCO Clinical Practice Guidelines: CYP2D6 Genotyping and Tamoxifen Efficacy.
- Goetz MP, Ratain M, Ingle JN.
- J Clin Oncol. 2016 Nov 10;34(32):3944-3945. doi: 10.1200/JCO.2016.68.5214.
- PMID: 27551126
- PubMed abstract
- Letter
- Free Full Text
-
- Genetic testing and interpretive complexity: a BRCA1 gene mutation example.
- Gogarty DS, Farrell MP, Gallagher DJ.
- Ir J Med Sci. 2016 Nov;185(4):955-957. Epub 2014 Dec 13.
- PMID: 25503966
- PubMed abstract
- Source abstract
-
- Prevention and Screening in Hereditary Breast and Ovarian Cancer.
- Zeichner SB, Stanislaw C, Meisel JL.
- Oncology (Williston Park). 2016 Oct 15;30(10). pii: 219285.
- PMID: 27753056
- PubMed abstract
- Source website
- Review
- Free Full Text
Commentary:
Clinical Hereditary Cancer Syndromes and Gene Panel Testing.
- PMID: 27753057
- PubMed abstract
- Free Full Text
-
- Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
- Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F, Song DH, Staley AC, Wilke LG, Willey SC, Yao KA, Margenthaler JA.
- Ann Surg Oncol. 2016 Oct;23(10):3100-5. doi: 10.1245/s10434-016-5443-5. Epub 2016 Jul 28.
- PMID: 27469117
- PubMed abstract
- Practice Guideline
- Free PMC article
- Free Full Text
Clinical Guideline:
Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.
- PMID: 27469118
- PubMed abstract
News: Contralateral Prophylactic Mastectomy Discouraged: ASBrS (Medscape Oncology)
-
- Consensus Guideline on Hereditary Genetic Testing for Patients With and Without Breast Cancer
- ASBS Research committee
- The American Society of Breast Surgeons. www.breastsurgeons.org. 2016 Sep 13.
- Practice Guideline
- Free Full Text (PDF)
Comments on NSGC Discussion Forum Cancer SIG:
Subject: American Society of Breast Surgeons Consenus Guidelines on Genetic Testing
Subject: American Society of Breast Surgeons Consenus Guidelines on Genetic Testing
-
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
- Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E; ESMO Guidelines Committee.
- Ann Oncol. 2016 Sep;27(suppl 5):v103-v110.
- PMID: 27664246
- PubMed abstract
- Source abstract
- Guidelines
- Free Full Text
-
- An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.
- Madorsky-Feldman D, Sklair-Levy M, Perri T, Laitman Y, Paluch-Shimon S, Schmutzler R, Rhiem K, Lester J, Karlan BY, Singer CF, Van Maerken T, Claes K, Brunet J, Izquierdo A, Teulé A, Lee JW, Kim SW, Arun B, Jakubowska A, Lubinski J, Tucker K, Poplawski NK, Varesco L, Bonelli LA, Buys SS, Mitchell G, Tischkowitz M, Gerdes AM, Seynaeve C, Robson M, Kwong A, Tung N, Tessa N, Domchek SM, Godwin AK, Rantala J, Arver B, Friedman E.
- Breast Cancer Res Treat. 2016 Jun;157(2):319-27. doi: 10.1007/s10549-016-3805-0. Epub 2016 Apr 27.
- PMID: 27117159
- PubMed abstract
- Source abstract
-
- Evolving Approaches in Research and Care for Ovarian Cancers: A Report From the National Academies of Sciences, Engineering, and Medicine.
- Levine DA, Karlan BY, Strauss JF 3rd.
- JAMA. 2016 May 10;315(18):1943-4. doi: 10.1001/jama.2016.2640.
- PMID: 26934631
- PubMed abstract
- Source abstract
-
- The Problem of Mammographic Breast Density - The Position of the DEGUM Working Group on Breast Ultrasound.
- Mueller-Schimpfle MP, Brandenbusch VC, Degenhardt F, Duda V, Madjar H, Mundinger A, Rathmann R, Hahn M.
- Ultraschall Med. 2016 Apr;37(2):170-175. Epub 2016 Feb 16.
- PMID: 26882482
- PubMed abstract
- Source abstract
-
- Committee Opinion No. 659 Summary: The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer.
- [No authors listed]
- Obstet Gynecol. 2016 Mar;127(3):618-9. doi: 10.1097/AOG.0000000000001349.
- PMID: 26901332
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG:
Subject: ACOG opinion Vaginal estrogen and women with ER pos breast ca
-
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
- Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.
- J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.
- PMID: 26850485
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG:
-
- SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
- Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teulé A, Lastra E, Brunet J, Balmaña J, Graña B; SEOM Hereditary Cancer Working Group.
- Clin Transl Oncol. 2015 Dec;17(12):956-61. doi: 10.1007/s12094-015-1435-3. Epub 2015 Dec 15.
- PMID: 26669313
- PubMed abstract
-
- Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.
- Singer CF, Tea MK, Pristauz G, Hubalek M, Rappaport C, Riedl CC, Helbich TH.
- Wien Klin Wochenschr. 2015 Dec;127(23-24):981-6. doi: 10.1007/s00508-015-0880-x. Epub 2015 Nov 2.
- PMID: 26525377
- PubMed abstract
- Source abstract
-
- Chemoprevention for Breast Cancer.
- Pruthi S, Heisey RE, Bevers TB.
- Ann Surg Oncol. 2015 Oct;22(10):3230-5. doi: 10.1245/s10434-015-4715-9. Epub 2015 Jul 23.
- PMID: 26202562
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.
- Caiata-Zufferey M, Pagani O, Cina V, Membrez V, Taborelli M, Unger S, Murphy A, Monnerat C, Chappuis PO.
- Genet Med. 2015 Sep 2;17(9):726-32. doi: 10.1038/gim.2014.183. Epub 2014 Dec 11.
- PMID: 25503500
- PubMed abstract
- Source abstract
-
- BRCA2-associated pancreatic cancer and current screening guidelines.
- Kasi PM, Pedersen KS, McWilliams RR.
- Cancer. 2015 Sep 1;121(17):3046. doi: 10.1002/cncr.29447. Epub 2015 May 27.
- PMID: 26018189
- PubMed abstract
- Source abstract
Comment:
Reply to BRCA2-associated pancreatic cancer and current screening guidelines.
- PMID: 27022824
- PubMed abstract
- Source abstract
-
- Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention.
- Del Sole A, Cinquetti S, Fedato C, Montagna M, Russo F, Sbrogiò LG, Zorzi M.
- Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):99-101.
- PMID: 26499424
- PubMed abstract
-
- AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2015.
- Hanf V, Schütz F, Liedtke C, Thill M; AGO Breast Committee.
- Breast Care (Basel). 2015 Jul;10(3):189-97. doi: 10.1159/000431346. Epub 2015 Jun 18.
- PMID: 26557824
- PubMed abstract
- Source abstract
-
- Breast Cancer Risk Reduction, Version 2.2015.
- Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, Laronga C, Layman RM, Loftus LS, Mahoney MC, Merajver SD, Meszoely IM, Mortimer J, Newman L, Pritchard E, Pruthi S, Seewaldt V, Specht MC, Visvanathan K, Wallace A, Bergman MA, Kumar R.
- J Natl Compr Canc Netw. 2015 Jul;13(7):880-915.
- PMID: 26150582
- PubMed abstract
- Source abstract
-
- Barriers to the Use of Breast Cancer Risk Reduction Therapies.
- Bambhroliya A, Chavez-MacGregor M, Brewster AM.
- J Natl Compr Canc Netw. 2015 Jul;13(7):927-35.
- PMID: 26150584
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Clinical management of women at high risk of breast cancer.
- Wuttke M, Phillips KA.
- Curr Opin Obstet Gynecol. 2015 Feb;27(1):6-13. doi: 10.1097/GCO.0000000000000140.
- PMID: 25502281
- PubMed abstract
- Source abstract
-
- Hereditary breast cancer syndromes and genetic testing.
- Rich TA, Woodson AH, Litton J, Arun B.
- J Surg Oncol. 2015 Jan;111(1):66-80. doi: 10.1002/jso.23791. Epub 2014 Nov 7.
- PMID: 25381882
- PubMed abstract
- Source abstract
-
- Committee opinion no. 620: salpingectomy for ovarian cancer prevention.
- [No authors listed]
- Obstet Gynecol. 2015 Jan;125(1):279-81. doi: 10.1097/01.AOG.0000459871.88564.09.
- PMID: 25560145
- PubMed abstract
-
- Hormonal and Surgical Treatment in Trans-Women with BRCA1 Mutations: A Controversial Topic.
- Colebunders B, T'Sjoen G, Weyers S, Monstrey S.
- J Sex Med. 2014 Oct;11(10):2496-9. doi: 10.1111/jsm.12628. Epub 2014 Jul 10.
- PMID: 25042481
- PubMed abstract
- Source abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: Cancer risks for transgender patient
-
- Risk determination and prevention of breast cancer.
- Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM, Harvie MN.
- Breast Cancer Res. 2014 Sep 28;16(5):446. doi: 10.1186/s13058-014-0446-2.
- PMID: 25467785
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Genetic/Familial high-risk assessment: breast and ovarian, version 1.2014.
- Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R.
- J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38.
- PMID: 25190698
- PubMed abstract
- Source abstract
-
- AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.
- Liedtke C, Thill M, Hanf V, Schütz F; AGO Breast Committee.
- Breast Care (Basel). 2014 Jul;9(3):189-200. doi: 10.1159/000363591.
- PMID: 25177261
- PubMed abstract
-
- Hereditary gynecologic cancers.
- Mutch D, Denny L, Quinn M; FIGO Committee on Gynecologic Oncology.
- Int J Gynaecol Obstet. 2014 Mar;124(3):189-92. doi: 10.1016/j.ijgo.2013.12.001. Epub 2013 Dec 21.
- PMID: 24429354
- PubMed abstract
- Source abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.
- Ann Intern Med. 2014 Feb 18;160(4):255-66.
- PMID: 24366442
- PubMed abstract
- Review
- Free Full Text
Quality-assessed Review: Database of Abstracts of Reviews of Effects (DARE) (PubMed Health)
-
- Assessing the Genetic Risk for BRCA-Related Breast or Ovarian Cancer in Women: Recommendations From the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4). doi: 10.7326/P14-9008.
- PMID: 24366402
- PubMed abstract
- Summary for Patients
- Free Full Text
Systematic Review:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- PMID: 24366442
- PubMed abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- Moyer VA; U.S. Preventive Services Task Force.
- Ann Intern Med. 2014 Feb 18;160(4):271-81.
- PMID: 24366376
- PubMed abstract
- Practice Guideline
- Free Full Text
Patient Education Handout:
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- PMID: 25006622
- PubMed abstract
-
- Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4):I-16.
- PMID: 25006622
- PubMed abstract
- Summary for Patients
- Free Full Text
Practice Guideline:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- PMID: 24366376
- PubMed abstract
-
- Risk management options elected by women after testing positive for a BRCA mutation.
- Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB.
- Gynecol Oncol. 2014 Feb;132(2):428-33. doi: 10.1016/j.ygyno.2013.12.014. Epub 2013 Dec 16.
- PMID: 24355485
- PubMed abstract
- Source abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation [Internet].
- Nelson HD, Fu R, Goddard K, Mitchell JP, Okinaka-Hu L, Pappas M, Zakher B (Editors).
- Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Dec. Report No.: 12-05164-EF-1. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews.
- PMID: 24432435
- PubMed Free Full Text
Practice Statement: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women (U.S. Preventive Services Task Force Recommendation Statement)
-
- Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
- Richter S, Haroun I, Graham TC, Eisen A, Kiss A, Warner E.
- Ann Oncol. 2013 Nov;24 Suppl 8:viii69-viii74. doi: 10.1093/annonc/mdt312.
- PMID: 24131974
- PubMed abstract
- Source abstract
-
- Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- [No author given]
- U.S. Preventive Services Task Force (USPSTF). 2013 Sep 24.
- Practice Guideline
- Free Full Text
-
- Use of pharmacologic interventions for breast cancer risk reduction: american society of clinical oncology clinical practice guideline.
- Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM.
- J Clin Oncol. 2013 Aug 10;31(23):2942-62. doi: 10.1200/JCO.2013.49.3122. Epub 2013 Jul 8.
- PMID: 23835710
- PubMed abstract
- Source abstract
- Practice Guideline, Meta-Analysis, Review
- Free Full Text
-
- Establishing a program for individuals at high risk for breast cancer.
- Cadiz F, Kuerer HM, Puga J, Camacho J, Cunill E, Arun B.
- J Cancer. 2013 Jul 1;4(5):433-46. doi: 10.7150/jca.6481. Print 2013.
- PMID: 23833688
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk.
- Tilanus-Linthorst MM, Lingsma HF, Evans DG, Thompson D, Kaas R, Manders P, van Asperen CJ, Adank M, Hooning MJ, Kwan Lim GE, Eeles R, Oosterwijk JC, Leach MO, Steyerberg EW.
- Int J Cancer. 2013 Jul;133(1):156-63. doi: 10.1002/ijc.28014. Epub 2013 Feb 13.
- PMID: 23292943
- PubMed abstract
- Source abstract
-
- NICE recommends preventive drugs for breast cancer.
- Wise J.
- BMJ. 2013 Jun 25;346:f4116. doi: 10.1136/bmj.f4116.
- PMID: 23801701
- PubMed abstract
- Source abstract
-
- Drugs to be offered to women at high risk of breast cancer.
- [No author given]
- NHS. News. 2013 Jun 6.
- News
- Free Full Text
-
- Experience of Risk-reducing Salpingo-oophorectomy for a BRCA1 Mutation Carrier and Establishment of a System Performing a Preventive Surgery for Hereditary Breast and Ovarian Cancer Syndrome in Japan: Our Challenges for the Future.
- Hirasawa A, Masuda K, Akahane T, Tsuruta T, Banno K, Makita K, Susumu N, Jinno H, Kitagawa Y, Sugano K, Kosaki K, Aoki D.
- Jpn J Clin Oncol. 2013 May;43(5):515-9. doi: 10.1093/jjco/hyt036. Epub 2013 Mar 13.
- PMID: 23487443
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- NICE launches consultation on familial breast cancer guidelines.
- Simon Leese.
- PHG Foundation. 2013 Jan 15.
- News
- Free Full Text
-
- Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines.
- Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS.
- Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):146-9. doi: 10.1158/1055-9965.EPI-12-0570. Epub 2012 Oct 23.
- PMID: 23093547
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG:
Subject: Breast cancer risk models
Subject: Tyrer-Cuzick model
-
- Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
- Moyer VA; U.S. Preventive Services Task Force.
- Ann Intern Med. 2012 Dec 18;157(12):900-4. doi: 10.7326/0003-4819-157-11-201212040-00539.
- PMID: 22964825
- PubMed abstract
- Practice Guideline
- Free Full Text
Summary for patients:
Summaries for patients. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
- PMID: 23362519
- PubMed abstract
- Free Full Text
Study Synopsis and Perspective, CME: Who Should Be Screened for Ovarian Cancer? (Medscape Education Clinical Briefs)
-
- Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument.
- Simone B, De Feo E, Nicolotti N, Ricciardi W, Boccia S.
- BMC Med. 2012 Nov 21;10:143. doi: 10.1186/1741-7015-10-143.
- PMID: 23171648
- PubMed abstract
-
- [Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].
- Singer CF, Tea MK, Pristauz G, Hubalek M, Rappaport C, Riedl C, Helbich T.
- Wien Klin Wochenschr. 2012 May;124(9-10):334-9. doi: 10.1007/s00508-012-0173-6. Epub 2012 May 28.
- PMID: 22644217
- PubMed abstract
- Source abstract